Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
161,353
archived clinical trials in
Cancer

Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
A Phase I Trial to Determine the Safety, Tolerability and Maximum Tolerated Intravesical Dose of Aminophylline With BCG in Patients With Non-invasive Bladder Cancer
Status: Enrolling
Updated:  11/12/2010
University of Virginia Urology Department
mi
from
Charlottesville, VA
Study of BCG + Aminophylline Toxicity When Used in the Treatment of Bladder Cancer
A Phase I Trial to Determine the Safety, Tolerability and Maximum Tolerated Intravesical Dose of Aminophylline With BCG in Patients With Non-invasive Bladder Cancer
Status: Enrolling
Updated: 11/12/2010
University of Virginia Urology Department
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
U.S.C./Norris Comprehensive Cancer Center
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Mercy Research Institute
mi
from
Miami, FL
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Mercy Research Institute
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
University of Miami
mi
from
Miami, FL
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
University of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Rush University Medical Center
mi
from
Chicago, IL
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Rush University Medical Center
mi
from
Chicago, IL
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
University of Maryland Greenebaum Cancer Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Massachusetts General Hospital
mi
from
Boston, MA
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Massachusetts General Hospital
mi
from
Boston, MA
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
University of New Mexico Cancer Center
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Weill Medical Cornell University
mi
from
New York, NY
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Weill Medical Cornell University
mi
from
New York, NY
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Stony Brook Cancer Center (SUNY)
mi
from
Stony Brook, NY
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Stony Brook Cancer Center (SUNY)
mi
from
Stony Brook, NY
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Providence Portland Medical Center
mi
from
Portland, OR
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Providence Portland Medical Center
mi
from
Portland, OR
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
Abramson Cancer Center of Uof Pennsylvania
mi
from
Philadelphia, PA
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
Abramson Cancer Center of Uof Pennsylvania
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated:  11/23/2010
West Virginia University Clinical Trials Research Unit
mi
from
Morgantown, WV
Phase 2 Study of Efficacy and Safety of Apricoxib/Placebo With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Randomized, Double-Blind, Placebo-Controlled Multicenter Phase 2 Study of the Efficacy and Safety of Apricoxib in Combination With Either Docetaxel or Pemetrexed in Non-Small Cell Lung Cancer Patients
Status: Enrolling
Updated: 11/23/2010
West Virginia University Clinical Trials Research Unit
mi
from
Morgantown, WV
Click here to add this to my saved trials
Genetic Susceptibility to Kidney Cancer
Genetic Susceptibility to Renal Cell Carcinoma
Status: Enrolling
Updated:  12/2/2010
M.D. Anderson Cancer Center
mi
from
Houston, TX
Genetic Susceptibility to Kidney Cancer
Genetic Susceptibility to Renal Cell Carcinoma
Status: Enrolling
Updated: 12/2/2010
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Screening for Bladder Cancer
Screening for Bladder Cancer
Status: Enrolling
Updated:  12/9/2010
Univ of Rochester Medical Center
mi
from
Rochester, NY
Screening for Bladder Cancer
Screening for Bladder Cancer
Status: Enrolling
Updated: 12/9/2010
Univ of Rochester Medical Center
mi
from
Rochester, NY
Click here to add this to my saved trials
Screening for Bladder Cancer
Screening for Bladder Cancer
Status: Enrolling
Updated:  12/9/2010
M.D. Anderson Cancer Center
mi
from
Houston, TX
Screening for Bladder Cancer
Screening for Bladder Cancer
Status: Enrolling
Updated: 12/9/2010
M.D. Anderson Cancer Center
mi
from
Houston, TX
Click here to add this to my saved trials
Ceftriaxone in Non-neutropenic Fever
Ceftriaxone in Non-neutropenic Fever
Status: Enrolling
Updated:  1/3/2011
Monroe Carrell Jr Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Ceftriaxone in Non-neutropenic Fever
Ceftriaxone in Non-neutropenic Fever
Status: Enrolling
Updated: 1/3/2011
Monroe Carrell Jr Children's Hospital at Vanderbilt
mi
from
Nashville, TN
Click here to add this to my saved trials
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors: The Role of Aromatase Inhibitors
Status: Enrolling
Updated:  1/6/2011
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors
Oral Health and Oral Health-Related Quality of Life in Early Stage Breast Cancer Survivors: The Role of Aromatase Inhibitors
Status: Enrolling
Updated: 1/6/2011
Michigan Center for Oral Health Research
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An Intervention to Improve Outcomes in Patients With Advanced Cancer
An Intervention to Improve Outcomes in Patients With Advanced Cancer
Status: Enrolling
Updated:  1/6/2011
Yale New Haven Hospital/Smilow Cancer Hospital
mi
from
New Haven, CT
An Intervention to Improve Outcomes in Patients With Advanced Cancer
An Intervention to Improve Outcomes in Patients With Advanced Cancer
Status: Enrolling
Updated: 1/6/2011
Yale New Haven Hospital/Smilow Cancer Hospital
mi
from
New Haven, CT
Click here to add this to my saved trials
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/31/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/31/2011
Dana-Farber Cancer Institute
mi
from
Boston, MA
Click here to add this to my saved trials
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/31/2011
Fox Chase Cancer Center
mi
from
Philadephia, PA
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/31/2011
Fox Chase Cancer Center
mi
from
Philadephia, PA
Click here to add this to my saved trials
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated:  1/31/2011
The Vanderbilt-Ingram Cancer Center
mi
from
Nashville,, TN
Phase I Safety Study of the Drug MM-121 in Patients With Advanced Solid Tumors Resisting Ordinary Treatment
A Phase I and Pharmocologic Study of MM-121 in Patients With Refractory Advanced Solid Tumors
Status: Enrolling
Updated: 1/31/2011
The Vanderbilt-Ingram Cancer Center
mi
from
Nashville,, TN
Click here to add this to my saved trials
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated:  2/3/2011
Emory University
mi
from
Atlanta, GA
Safety and Efficacy Study of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
A Phase II Trial of Gemcitabine Plus Bevacizumab in Patients With Platinum-Resistant Ovarian, Primary Peritoneal or Fallopian Tube Cancer
Status: Enrolling
Updated: 2/3/2011
Emory University
mi
from
Atlanta, GA
Click here to add this to my saved trials
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients With Sentinel Lymph Nodes Determined to be Negative for Metastatic Disease.
Status: Enrolling
Updated:  2/9/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients.
Conservative Management With Isolated Sentinel Lymph Node Biopsy in Vulvar Cancer Patients With Sentinel Lymph Nodes Determined to be Negative for Metastatic Disease.
Status: Enrolling
Updated: 2/9/2011
Women and Infants Hospital of Rhode Island
mi
from
Providence, RI
Click here to add this to my saved trials
Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
Fast Absorbing Gut Suture Versus Cyanoacrylate Tissue Adhesive in the Epidermal Closure of Linear Repairs Following Mohs Micrographic Surgery
Status: Enrolling
Updated:  2/15/2011
Yale Dermatologic Surgery
mi
from
New Haven, CT
Absorbable Suture Versus Tissue Glue to Repair Defects Following Mohs Surgery
Fast Absorbing Gut Suture Versus Cyanoacrylate Tissue Adhesive in the Epidermal Closure of Linear Repairs Following Mohs Micrographic Surgery
Status: Enrolling
Updated: 2/15/2011
Yale Dermatologic Surgery
mi
from
New Haven, CT
Click here to add this to my saved trials
Breast Cancer Prevention Education
Disseminating Breast Cancer Prevention to African American Women
Status: Enrolling
Updated:  2/17/2011
University of Pennsylvania Center for Community Based Research and Health Disparities
mi
from
Philadelphia, PA
Breast Cancer Prevention Education
Disseminating Breast Cancer Prevention to African American Women
Status: Enrolling
Updated: 2/17/2011
University of Pennsylvania Center for Community Based Research and Health Disparities
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Identification of a Gene Expression Signature Profile for Panitumumab Sensitivity in Untreated Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Status: Enrolling
Updated:  2/25/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Identification of a Gene Expression Signature Profile for Panitumumab Sensitivity in Untreated Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Status: Enrolling
Updated: 2/25/2011
University of North Carolina at Chapel Hill
mi
from
Chapel Hill, NC
Click here to add this to my saved trials
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Identification of a Gene Expression Signature Profile for Panitumumab Sensitivity in Untreated Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Status: Enrolling
Updated:  2/25/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Identification of Gene Expression Signature for Panitumumab Sensitivity in Untreated Locally Advanced SCCHN
Identification of a Gene Expression Signature Profile for Panitumumab Sensitivity in Untreated Locally Advanced Squamous Cell Cancer of the Head and Neck (SCCHN)
Status: Enrolling
Updated: 2/25/2011
Duke Univ Med Ctr
mi
from
Durham, NC
Click here to add this to my saved trials
64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab
A Pilot Study of 64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer Patients Treated With Carboplatin, Paclitaxel, and Bevacizumab
Status: Enrolling
Updated:  2/25/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer With Carboplatin, Paclitaxel, and Bevacizumab
A Pilot Study of 64CuATSM and Hypoxia in Stage IV Non-small Cell Lung Cancer Patients Treated With Carboplatin, Paclitaxel, and Bevacizumab
Status: Enrolling
Updated: 2/25/2011
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Phase II Clinical Trial of Cisplatin + Gemcitabine in Combination With Mild, Fever-Range Whole-Body Hyperthermia to Treat Patients With Advanced, Inoperable Pancreatic Cancer
Status: Enrolling
Updated:  3/2/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Hyperthermia With Chemotherapy for Locally Advanced or Metastatic Pancreas Cancer
Phase II Clinical Trial of Cisplatin + Gemcitabine in Combination With Mild, Fever-Range Whole-Body Hyperthermia to Treat Patients With Advanced, Inoperable Pancreatic Cancer
Status: Enrolling
Updated: 3/2/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer)
Status: Enrolling
Updated:  3/2/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Hyperthermia/Thermal Therapy With Chemotherapy to Treat Inoperable or Metastatic Tumors
A Phase II Clinical Trial of Cisplatin + Gemcitabine HCl (GEM) + Low-Dose Metronomic Interferon-a (IFN-a) Combined With Fever-Range Whole-Body Thermal Therapy (FR-WB-TT) in Patients With Metastatic/or Locally Advanced Malignancies (Small-Cell Lung Cancer, Neuroendocrine Cancer, Gastric Cancer)
Status: Enrolling
Updated: 3/2/2011
Memorial Hermann Hospital
mi
from
Houston, TX
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
A Phase I Study of Erlotinib in Patients With Premalignant Lesions of the Lung
Status: Enrolling
Updated:  3/9/2011
Northwestern University
mi
from
Chicago, IL
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
A Phase I Study of Erlotinib in Patients With Premalignant Lesions of the Lung
Status: Enrolling
Updated: 3/9/2011
Northwestern University
mi
from
Chicago, IL
Click here to add this to my saved trials
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
A Phase I Study of Erlotinib in Patients With Premalignant Lesions of the Lung
Status: Enrolling
Updated:  3/9/2011
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Erlotinib Hydrochloride in Treating Patients With Previously Treated Non-Small Cell Lung Cancer, Head and Neck Cancer, or Esophageal Cancer and Precancerous Lesions of the Lung
A Phase I Study of Erlotinib in Patients With Premalignant Lesions of the Lung
Status: Enrolling
Updated: 3/9/2011
Roswell Park Cancer Institute
mi
from
Buffalo, NY
Click here to add this to my saved trials
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Reduced Intensity Stem Cell Transplant in Children and Young Adults Utilizing Photopheresis, Fludarabine, and Busulfan
Status: Enrolling
Updated:  3/10/2011
Children's Memorial Hospital
mi
from
Chicago, IL
Reduced Intensity Transplant Using Extracorporeal Photopheresis
Reduced Intensity Stem Cell Transplant in Children and Young Adults Utilizing Photopheresis, Fludarabine, and Busulfan
Status: Enrolling
Updated: 3/10/2011
Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
Phase 1 Toxicity/Feasibility Study: Combined Modality Treatment With Transimmunization for Non-Small Cell Lung Cancer
Status: Enrolling
Updated:  3/21/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Safety Study: Combined Modality Treatment for Non-Small Cell Lung Cancer
Phase 1 Toxicity/Feasibility Study: Combined Modality Treatment With Transimmunization for Non-Small Cell Lung Cancer
Status: Enrolling
Updated: 3/21/2011
Morristown Memorial Hospital
mi
from
Morristown, NJ
Click here to add this to my saved trials
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Status: Enrolling
Updated:  3/21/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Radical Cystectomy: Can We Improve Our Surgical Technique With the Ligasure Impact Tissue-Sealing Device?
Status: Enrolling
Updated: 3/21/2011
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Status: Enrolling
Updated:  4/14/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Treatment of Refractory Metastatic Renal Cell Carcinoma With Bevacizumab and RADOO1
Status: Enrolling
Updated: 4/14/2011
Stanford University School of Medicine
mi
from
Stanford, CA
Click here to add this to my saved trials
UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
Status: Enrolling
Updated:  4/20/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
UAB 0718 - Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
Phase II Trial to Assess Target Oral Therapy as Adjuvant Chemoprevention in High-Risk Head and Neck Cancer
Status: Enrolling
Updated: 4/20/2011
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Status: Enrolling
Updated:  4/21/2011
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Platelet Modulation: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Platelet Modulation in the Control of Angiogenesis: A Study of Angiogenic and Coagulation Proteins in Patients With Cancer
Status: Enrolling
Updated: 4/21/2011
University of Vermont/Fletcher Allen Health Care
mi
from
Burlington, VT
Click here to add this to my saved trials
Dental Study in Cancer Patients With Central Venous Catheters
Pilot Study on Transient Bacteremia and Blood Stream Infections After Invasive Dental Procedures in Cancer Patients With Central Venous Catheters
Status: Enrolling
Updated:  5/2/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Dental Study in Cancer Patients With Central Venous Catheters
Pilot Study on Transient Bacteremia and Blood Stream Infections After Invasive Dental Procedures in Cancer Patients With Central Venous Catheters
Status: Enrolling
Updated: 5/2/2011
University of Connecticut Health Center
mi
from
Farmington, CT
Click here to add this to my saved trials
Partial Breast Irradiation in a Low-risk Population Screened With MRI
Image Guided Partial Breast Irradiation (PBL) In A Low-Risk Population Screened With Magnetic Resonance Imaging (MRI)
Status: Enrolling
Updated:  5/23/2011
University of Chicago
mi
from
Chicago, IL
Partial Breast Irradiation in a Low-risk Population Screened With MRI
Image Guided Partial Breast Irradiation (PBL) In A Low-Risk Population Screened With Magnetic Resonance Imaging (MRI)
Status: Enrolling
Updated: 5/23/2011
University of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Phase I/II Study of a Therapeutic Cancer Vacccine Created In-situ in Patients With Refractory or Metastatic Cancer
Status: Enrolling
Updated:  6/6/2011
Immunovative Clinical Research, Inc
mi
from
Carlsbad, CA
In-Situ Therapeutic Cancer Vaccine for Metastatic Cancer Combining AlloStim With Tumor Cryoablation
Phase I/II Study of a Therapeutic Cancer Vacccine Created In-situ in Patients With Refractory or Metastatic Cancer
Status: Enrolling
Updated: 6/6/2011
Immunovative Clinical Research, Inc
mi
from
Carlsbad, CA
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
UCLA
mi
from
Los Angeles, CA
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
UCLA
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Mayo Clinic - Jacksonville, Florida
mi
from
Jacksonville, FL
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Mayo Clinic - Jacksonville, Florida
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
University of Louisville
mi
from
Louisville, KY
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
University of Louisville
mi
from
Louisville, KY
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Mayo Clinic Rochester
mi
from
Rochester, MN
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Mayo Clinic Rochester
mi
from
Rochester, MN
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Mount Sinai School of Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Cleveland Clinic
mi
from
Cleveland, OH
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Temple University Hospital
mi
from
Philadelphia, PA
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated:  6/7/2011
Geisinger Health System
mi
from
Wilkes Barre, PA
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
A Phase III, Randomized, Double-Blinded, Dummy-Controlled Study of the Efficacy and Safety of ThermoDox® (Thermally Sensitive Liposomal Doxorubicin) in Combination With Radiofrequency Ablation (RFA) Compared to RFA-Alone in the Treatment of Non-Resectable Hepatocellular Carcinoma
Status: Enrolling
Updated: 6/7/2011
Geisinger Health System
mi
from
Wilkes Barre, PA
Click here to add this to my saved trials